The next steps for TGR-1202 and targeting the gene c-Myc
Panel discussion on large cell lymphomas: subtypes, patient selection and mutations
Andrew Zelenetz et al.
The multi-cohort SCHOLAR-1 study of refractory aggressive DLBCL
The potential clinical implications of targeted therapies for DLBCL and why the situation is complex
Targeted molecular signatures of DLBCL and upcoming CheckMate 647 trial for PCNSL and PTL